Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Stockholders' Equity (Deficit) (Unaudited)

v3.20.2
Consolidated Statements of Stockholders' Equity (Deficit) (Unaudited) - USD ($)
Preferred Series A Stock [Member]
Preferred Series B Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Deficit [Member]
Non-Controlling Interest [Member]
Total
Beginning Balance at Dec. 31, 2018 $ 33,661 $ 3,566,339 $ (9,296,408) $ (370,132) $ (6,066,540)
Beginning Balance, Shares at Dec. 31, 2018 33,661,388        
Purchase accounting entries due to the purchase transaction $ 9 $ 24,717 12,657,182 12,681,908
Purchase accounting entries due to the purchase transaction, shares 9,250 24,717,217        
Adjustment for assets and liabilities not included purchase transaction 5,244,780 5,244,780
Issuance of Common Stock in connection with private placement offering $ 17,700 4,402,087 4,419,787
Issuance of Common Stock in connection with private placement offering, shares 17,700,000        
Issuance of warrants in connection with private placement offering 2,663,797 2,663,797
Issuance of common stock in exchange for consulting services     $ 130        
Issuance of common stock in exchange for consulting services, shares     130,085        
Issuance of common stock pursuant to conversion of short-term debt $ 500 125,437 125,937
Issuance of common stock pursuant to conversion of short-term debt, shares 500,000        
Issuance of warrants pursuant to conversion of short-term debt 74,063 74,063
Issuance of additional exchange shares $ 17,264 (17,264)
Issuance of additional exchange shares, shares 17,263,889        
Issuance of Common Stock pursuant to conversion of convertible short-term debt $ 250 99,750 100,000
Issuance of Common Stock pursuant to conversion of convertible short-term debt, shares 250,000        
Conversion of Preferred Series B Stock and accrued dividends $ (2) $ 605 (603)
Conversion of Preferred Series B Stock and accrued dividends, shares (2,250) 604,167        
Issuance of Common Stock to pay accrued interest on convertible short-term debt $ 2 665 (667)
Issuance of Common Stock to pay accrued interest on convertible short-term debt, shares 1,667        
Series B Stock accrued dividend $ 32 12,894 12,926
Series B Stock accrued dividend, shares 32,313        
Issuance of Common Stock in exchange for consulting fees incurred $ 280 95,254 95,534
Issuance of Common Stock in exchange for consulting fees incurred, shares 280,085        
Adjustment of exercise price on convertible debt 287,542 (287,542)
Adjustment of exercise price on convertible debt, shares        
Reclassification of Series B warrants to equity            
Reclassification of Series D warrants to equity            
Beneficial conversion of Series B Preferred Stock 32,592 (32,592)
Issuance of Common Stock per restricted stock award to executive $ 4,226 1,686,028 1,690,254
Issuance of Common Stock per restricted stock award to executive, shares 4,225,634        
Issuance of warrants pursuant to extension of maturity date on convertible debt 106,158 106,158
Stock based compensation 93,632 93,632
Dividends payable (66,639) (66,639)
Issuance of warrants pursuant to extension of convertible short-term notes            
Net Income (loss) (11,615,750) (11,615,750)
Ending Balance at Sep. 30, 2019 $ 7 $ 99,237 25,818,913 (15,987,512) (370,132) 9,560,513
Ending Balance, shares at Sep. 30, 2019 7,000 99,236,360        
Beginning Balance at Dec. 31, 2018 $ 33,661 3,566,339 (9,296,408) (370,132) (6,066,540)
Beginning Balance, Shares at Dec. 31, 2018 33,661,388        
Ending Balance at Dec. 31, 2019 $ 6 $ 99,769 28,172,146 (37,362,531) (370,132) (9,460,742)
Ending Balance, shares at Dec. 31, 2019 6,100 99,768,704        
Beginning Balance at Jun. 30, 2019 $ 7 $ 98,887 25,705,975 (13,480,691) (370,132) 11,954,046
Beginning Balance, Shares at Jun. 30, 2019 7,000 98,886,360        
Issuance of Common Stock in connection with private placement offering $ 200 77,164 77,364
Issuance of Common Stock in connection with private placement offering, shares 200,000        
Issuance of warrants in connection with private placement offering 22,636 22,636
Issuance of common stock in exchange for consulting services $ 150 43,349 43,499
Issuance of common stock in exchange for consulting services, shares 150,000        
Derivative liability adjustment (116,842) 116,842
Issuance of warrants pursuant to extension of maturity date on convertible debt 106,158 106,158
Stock based compensation 1,473 1,473
Dividends payable (21,000) (21,000)
Net Income (loss) (2,623,663) (2,623,663)
Ending Balance at Sep. 30, 2019 $ 7 $ 99,237 25,818,913 (15,987,512) (370,132) 9,560,513
Ending Balance, shares at Sep. 30, 2019 7,000 99,236,360        
Beginning Balance at Dec. 31, 2019 $ 6 $ 99,769 28,172,146 (37,362,531) (370,132) (9,460,742)
Beginning Balance, Shares at Dec. 31, 2019 6,100 99,768,704        
Accrued dividends on Series B Preferred Stock (44,456) (44,456)
Issuance of Common Stock in exchange for consulting fees incurred $ 109 34,891 35,000
Issuance of Common Stock in exchange for consulting fees incurred, shares 109,375        
Issuance of warrants pursuant to private placement of Series D Convertible Preferred Stock 31,902 31,902
Issuance of warrants pursuant to private placement of Series D Convertible Preferred Stock,shares          
Adjustment of exercise price on certain warrants (438,913) (438,913)
Reclassification of Series B warrants to equity 73,805 73,805
Reclassification of Series D warrants to equity 337,400 337,400
Conversion of Series B Preferred Stock to Common Stock $ (6) $ 2,120 150,983 153,097
Conversion of Series B Preferred Stock to Common Stock, shares (6,100) 2,119,713        
Conversion of Series D Preferred Stock to Common Stock $ 15,773 6,422,441 6,438,214
Conversion of Series D Preferred Stock to Common Stock, shares 15,773,363        
Conversion of short-term related party convertible notes to Preferred Stock $ 35,860 412,541 448,401
Conversion of short-term related party convertible notes to Preferred Stock, shares 35,860,079        
Issuance of Common Stock in connection with extinguishment of short term notes, related parties $ 4,368 214,046 218,414
Issuance of Common Stock in connection with extinguishment of short term notes, related parties, shares 4,368,278        
Deemed dividend on Series D Preferred Stock (277,719) (277,719)
Deemed dividend on Series D Preferred Stock, shares        
Deemed dividend on Series D Preferred Stock at issuance (37,206) (37,206)
Conversion of related party warrants to equity 107,123 107,123
Conversion of related party warrants to equity, shares        
Conversion of Short-term convertible notes to Preferred Stock $ 287,984 4,751,484 5,039,468
Conversion of Short-term convertible notes to Preferred Stock, shares 287,984,337        
Issuance of Series A Preferred Stock in Rights Offering $ 218,285 2,517,451 2,735,736
Issuance of Series A Preferred Stock in Rights Offering, shares 218,285,024        
Issuance of warrants pursuant to extension of maturity date on convertible debt 6,595 6,595
Stock based compensation 643 643
Issuance of warrants pursuant to extension of convertible short-term notes 17,636 17,636
Net Income (loss) (4,898,685) (4,898,685)
Ending Balance at Sep. 30, 2020 $ 542,129 $ 122,139 42,489,998 (42,298,423) (370,132) 485,711
Ending Balance, shares at Sep. 30, 2020 542,129,440 122,139,433        
Beginning Balance at Jun. 30, 2020 $ 6 $ 104,246 27,761,076 (46,248,302) (370,132) (18,753,106)
Beginning Balance, Shares at Jun. 30, 2020 6,100 104,246,357        
Accrued dividends on Series B Preferred Stock (7,856) (7,856)
Conversion of Series B Preferred Stock to Common Stock $ (6) $ 2,120 150,983 153,097
Conversion of Series B Preferred Stock to Common Stock, shares (6,100) 2,119,713        
Conversion of Series D Preferred Stock to Common Stock $ 15,773 6,422,441 6,438,214
Conversion of Series D Preferred Stock to Common Stock, shares 15,773,363        
Conversion of short-term related party convertible notes to Preferred Stock $ 287,984 4,751,484 5,039,468
Conversion of short-term related party convertible notes to Preferred Stock, shares 287,984,337        
Deemed dividend on Series D Preferred Stock (36,450) (36,450)
Deemed dividend on Series D Preferred Stock, shares        
Conversion of related party warrants to equity 107,123 107,123
Conversion of related party warrants to equity, shares        
Conversion of Short-term convertible notes to Preferred Stock $ 35,860 412,541 448,401
Conversion of Short-term convertible notes to Preferred Stock, shares 35,860,079        
Issuance of Series A Preferred Stock in Rights Offering $ 218,285 2,517,451 2,735,736
Issuance of Series A Preferred Stock in Rights Offering, shares 218,285,024        
Reclassification of Series B warrants to Common Stock 73,805 73,805
Reclassification of Series D warrants to Common Stock 337,400 337,400
Net Income (loss) 3,949,879 3,949,879
Ending Balance at Sep. 30, 2020 $ 542,129 $ 122,139 $ 42,489,998 $ (42,298,423) $ (370,132) $ 485,711
Ending Balance, shares at Sep. 30, 2020 542,129,440 122,139,433